|
A Prospective Blood Sample Collection Study to Develop and Validate a Panel
of Protein-based Biomarkers in Patients with Pulmonary Nodules
Principal Investigator:
Victoria Giffi, MD
|
Enrolling
|
|
A Prospective Blood Sample Collection to Evaluate a Panel of Protein-Based
Biomarkers
Principal Investigator:
Victoria Giffi, MD
|
Closed
|
|
A Phase 3, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate
the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms
in Patients with Celiac Disease on a Gluten Free Diet
Principal Investigator:
Chintamaneni Choudari, MD
|
Enrolling
|
|
Diabetic Retinopathy Screening using Smartphone-Based Fundus Photography
and Artificial Intelligence. A Proof of Concept Study in a Community Based Clinic
Principal Investigator:
John Wroblewski, MD
Co-Investigator:
Jay Berdia, MD
|
Enrolling
|
|
A Phase 3, Multicenter. Randomized, Double-Blind, Placebo-Controlled Induction
and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538
in Adult and Adolescent Subjects with Eosinophilic Esophagitis
Principal Investigator:
Chintamaneni Choudari, MD
|
Enrolling
|
|
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
- Ascertaining Serial Cancer Patients to Enable New Diagnostic II (DETECT
-ASCEND 2)
Principal Investigator:
Victoria Giffi, MD
|
Enrolling
|
|
STOP-CANCER: Strategic Targeting for Optimal Prevention of Cancer
Principal Investigator:
Victoria Giffi, MD
|
Enrolling
|
|
Correct-MRD II: Seconds Colorectal Cancer Clinical Validation Study to
Predict Recurrence Using A Circulating Tumor DNA Assay To Detect Minimal
Residual Disease
Principal Investigator:
Victoria Giffi, MD
|
Enrolling
|
|
A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate
the Long-Term Safety of CC-93538 in Adult and adolescent Subjects with
Eosinophilic Esophagitis
Principal Investigator:
Chintamaneni Choudari, MD
|
Enrolling
|
|
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group
Phase 4 Study of the Efficacy and Safety of Patiromer for Oral Suspension
in Combination with the Standard of Care Treatment in Emergency Department
Patients with Hyperkalemia (PLATINUM)
Principal Investigator:
James Williams, DO
Co-Investigator:
Sridhar Gona
|
Enrolling
|
|
Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics
for the Diagnosis and Personalized Management of Patients
Principal Investigator:
Victoria Giffi, MD
|
